286 related articles for article (PubMed ID: 17088067)
1. In vitro cytotoxicity evaluation of some substituted isatin derivatives.
Vine KL; Locke JM; Ranson M; Benkendorff K; Pyne SG; Bremner JB
Bioorg Med Chem; 2007 Jan; 15(2):931-8. PubMed ID: 17088067
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.
Vine KL; Locke JM; Ranson M; Pyne SG; Bremner JB
J Med Chem; 2007 Oct; 50(21):5109-17. PubMed ID: 17887662
[TBL] [Abstract][Full Text] [Related]
3. N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents.
Matesic L; Locke JM; Bremner JB; Pyne SG; Skropeta D; Ranson M; Vine KL
Bioorg Med Chem; 2008 Mar; 16(6):3118-24. PubMed ID: 18182300
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
[TBL] [Abstract][Full Text] [Related]
5. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.
Kopka K; Faust A; Keul P; Wagner S; Breyholz HJ; Höltke C; Schober O; Schäfers M; Levkau B
J Med Chem; 2006 Nov; 49(23):6704-15. PubMed ID: 17154501
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.
Podichetty AK; Wagner S; Schröer S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
J Med Chem; 2009 Jun; 52(11):3484-95. PubMed ID: 19445513
[TBL] [Abstract][Full Text] [Related]
7. alpha-Bromoacrylamido N-substituted isatin derivatives as potent inducers of apoptosis in human myeloid leukemia cells.
Romagnoli R; Baraldi PG; Cruz-Lopez O; Preti D; Bermejo J; Estévez F
ChemMedChem; 2009 Oct; 4(10):1668-76. PubMed ID: 19670209
[TBL] [Abstract][Full Text] [Related]
8. Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors.
Podichetty AK; Wagner S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
Future Med Chem; 2009 Aug; 1(5):969-89. PubMed ID: 21426092
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of S-dialkylarsino-3-mercapto-1,2-propanediols and evaluation of their anticancer activity.
Gao M; Tan S; Chen Y; Zingaro RA
Bioorg Med Chem; 2007 Apr; 15(7):2660-6. PubMed ID: 17287125
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of heteroaryldiamides and heteroaryldiamines as cytotoxic agents, apoptosis inducers and caspase-3 activators.
Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Sanmartín C; Palop JA
Arch Pharm (Weinheim); 2006 Apr; 339(4):182-92. PubMed ID: 16572481
[TBL] [Abstract][Full Text] [Related]
13. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
[TBL] [Abstract][Full Text] [Related]
19. The novel C-5 aryl, alkenyl, and alkynyl substituted uracil derivatives of L-ascorbic acid: synthesis, cytostatic, and antiviral activity evaluations.
Gazivoda T; Raić-Malić S; Marjanović M; Kralj M; Pavelić K; Balzarini J; De Clercq E; Mintas M
Bioorg Med Chem; 2007 Jan; 15(2):749-58. PubMed ID: 17092728
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues.
Manley-King CI; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Jan; 19(1):261-74. PubMed ID: 21134756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
